EUROAPI EUROAPI

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Natco Pharma Limited

    Client Virtual Booth

    NATCO PHARMA LIMITED

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Natco Pharma Limited
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    NATCO HOUSE, Road No.2, Banjara Hills, Hyderabad-500 034
    Telephone
    Telephone
    +91-40-2354 7532
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.natcopharma.co.in/
    Linkedin
    Linkedin
    https://www.linkedin.com/company-beta/7851583/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr
    Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr

    https://www.indianpharmapost.com/news/natco-pharma-posts-consolidated-q2f-y24-pat-of-rs-369-cr-14901

    INDIAN PHARMA POST
    15 Nov 2023
    Share Share
    FDA slams Natco Pharma with Form 483 over sanitary, other issues
    FDA slams Natco Pharma with Form 483 over sanitary, other issues

    https://www.fiercepharma.com/manufacturing/fda-slams-natco-pharma-form-483-over-sanitary-quality-control-issues

    Joseph Keenan FIERCE PHARMA
    06 Nov 2023
    Share Share
    FDA Issues Form 483 to NATCO Pharma Limited
    FDA Issues Form 483 to NATCO Pharma Limited

    https://www.fda.gov/media/173542/download?attachment

    FDA
    01 Nov 2023
    Share Share
    Natco Pharma shares down as USFDA issues 8 observations for Hyderabad unit
    Natco Pharma shares down as USFDA issues 8 observations for Hyderabad unit

    https://www.moneycontrol.com/news/business/stocks/natco-pharma-shares-down-as-usfda-issues-8-observations-for-hyderabad-unit-11566431.html/amp

    MONEY CONTROL
    20 Oct 2023
    Share Share
    Natco Pharma, others sued in US for generic cancer drug
    Natco Pharma, others sued in US for generic cancer drug

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-others-sued-in-us-for-generic-cancer-drug/articleshow/103502980.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    08 Sep 2023
    Share Share
    Natco's Generic Tipiracil HCL, Trifluridine Receives Approval in the U.S.
    Natco's Generic Tipiracil HCL, Trifluridine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214008

    FDA
    13 Jun 2023
    Share Share
    India's Natco Pharma invests $3 M to set up subsidiary in Indonesia
    India's Natco Pharma invests $3 M to set up subsidiary in Indonesia

    https://www.biospectrumasia.com/news/25/22324/indias-natco-pharma-invests-3-m-to-set-up-subsidiary-in-indonesia.html

    BIOSPECTRUM ASIA
    21 Apr 2023
    Share Share
    Natco Pharma launches additional strengths of generic version of Revlimid in US
    Natco Pharma launches additional strengths of generic version of Revlimid in US

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-launches-additional-strengths-of-generic-version-of-revlimid-in-us/articleshow/98538080.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    10 Mar 2023
    Share Share
    Teva and Natco Announce Launch of additional strengths for Revlimid
    Teva and Natco Announce Launch of additional strengths for Revlimid

    https://www.businesswire.com/news/home/20230306005799/en

    BUSINESSWIRE
    09 Mar 2023
    Share Share
    Natco Pharma submits application with USFDA for generic cancer drug
    Natco Pharma submits application with USFDA for generic cancer drug

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-submits-application-with-usfda-for-generic-cancer-drug/articleshow/97864876.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    13 Feb 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    pfizer-centreone-m-2023-12-04

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search